Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in Raynaud's Phenomenon in Scleroderma
NCT00626665Phase 3Completed
- Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Start
- Dec 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tadalafil in Raynaud phenomenon, sponsored by Sanjay Gandhi Postgraduate Institute of Medical Sciences. Started Dec 2007; status: completed.
02
Drugs
tadalafil
03
Conditions
Raynaud phenomenon
Beyond the preview
Go deeper on NCT00626665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626665.